---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015874"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T00:51:17.552591+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cyclacel raises $3M via convertible preferred stock and warrants; cash runway into Q3 2025

## Summary
- Gross proceeds of $3.0M from sale of 3M shares of Series F Convertible Preferred at $1.00 per share.
- Each preferred share converts into 3.27 common shares; conversion requires stockholder approval per Nasdaq rules.
- Issued 29.43M warrants (Series A/B/C) at exercise prices $0.51, $0.60, $0.68, all expiring in 5 years.
- Net proceeds for working capital; combined with existing cash expected to fund operations into Q3 2025.
- Offering sold under Regulation S to non-U.S. accredited investors without a placement agent.

## SEC filing metadata
- accession: 0001641172-25-015874
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 1.01, 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000164117225015874/0001641172-25-015874-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000164117225015874/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015874
- JSON: https://secwatch.observer/filing/0001641172-25-015874.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015874.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.